Literature DB >> 2866742

Medical therapy for reflux esophagitis: 1986 and beyond.

D O Castell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2866742     DOI： 10.7326/0003-4819-104-1-112

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  4 in total

1.  Combined therapy with cisapride and cimetidine in severe reflux oesophagitis: a double blind controlled trial.

Authors:  J P Galmiche; G Brandstätter; M Evreux; E Hentschel; E Kerstan; P Kratochvil; W Reichel; K Schütze; J C Soule; J Vitaux
Journal:  Gut       Date:  1988-05       Impact factor: 23.059

2.  Effects of cisapride on parameters of oesophageal motility and on the prolonged intraoesophageal pH test in infants with gastro-oesophageal reflux disease.

Authors:  S Cucchiara; A Staiano; A Boccieri; M De Stefano; C Capozzi; G Manzi; F Camerlingo; F M Paone
Journal:  Gut       Date:  1990-01       Impact factor: 23.059

Review 3.  Maintenance therapy: is there still a place for antireflux surgery?

Authors:  D Armstrong; M Nicolet; P Monnier; G Chapuis; M Savary; A L Blum
Journal:  World J Surg       Date:  1992 Mar-Apr       Impact factor: 3.352

4.  Comparison of a dimethicone/antacid (Asilone gel) with an alginate/antacid (Gaviscon liquid) in the management of reflux oesophagitis.

Authors:  H L Smart; M Atkinson
Journal:  J R Soc Med       Date:  1990-09       Impact factor: 18.000
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.